Your search for "technical" return 48 results.
Hyogen® with ImuvantTM - Superior Protection Against Mycoplasma hyopneumoniae infection >
- Single injection provides early and long lasting protection - Broad stimulation of the immune system with ImuvantTM - Trials demonstrate superior protection versus competitors - Expertise of the...
VETRIMOXIN® LA - Technical profile >
Vetrimoxin® LA is the leading product in the Ceva anti-infective range. Within the group of historical antibiotics, the product has an extensive experience in the market as leader in its segment being...
C.H.I.C.K. Program Online - No.16 >
Hatchery vaccination - Toward a full control of vaccine administration
Ceva Lung Program - Overview >
The Ceva Lung Program (CLP) provides an overview of the diseases associated with Actinobacillus pleuropeumoniae, Mycoplasma hyopneumoniae and Aujeszky’s disease virus.
C.H.I.C.K. Program Online - No.15 >
Incubation and hatching processes - Main factors affecting the hatchability
Coglapix® - Economic benefit study versus an antibiotic in the control of A.P. >
The Vaccine group (with Coglapix®) and Antibiotic group have the higher performance and more profit than the Control group. Although the similar performance, the economic impact given by the Vaccine g...
C.H.I.C.K. Program Online - No.12 >
The day-old chick: a crucial hinge between breeders and broilers
Coglapix® and the procedure to control pleuro-pneumonia caused by Actinobacillus pleuropneumoniae (APP) >
In the recent years, the pig farms in the whole world always control APP following a strict process including diagnosis, prevention, treatment and regular monitoring together with good farm practices...
Pig biosecurity: Preventing disease with disinfectants >
Understand the needs of the pig farm and the properties of disinfectants available.
Porcine Pleuropneumonia: From A Good Detection To A Good Protection >
In this new issue of Axis, we would like to have anupdate on the swine pleuro-pneumonia, the management of the disease and the prevention possibilities. Ceva Santé Animale has developed a new vaccine,...